Greenwich LifeSciences, Inc. ( GLSI) - Stock Earnings
GLSI Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 13, 2026, midnight | — / — | — | — / — | — |
GLSI Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -7.9 million USD | — USD |
| 2026Q1 | -5.7 million USD | 3558 USD |
| 2026Q2 | -3.9 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
GLSI Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -8.9 million USD | — USD |
| 2024 | -17.4 million USD | — USD |
| 2025 | -19.4 million USD | — USD |
| 2026 Est. | — | — |
GLSI
Price: $14.55
52 week price:
Earnings Per Share: -1.58 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 30476
Market Capitalization: 238.8 million